Oxidative stress in the pathology and treatment of systemic lupus erythematosus

被引:0
|
作者
Andras Perl
机构
[1] Microbiology and Immunology,Departments of Medicine, Division of Rheumatology
[2] Biochemistry and Molecular Biology,undefined
[3] State University of New York,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress—generated through multiple mechanisms in a cell-type-specific manner—is a substantial contributor to disease pathogenesis, organ damage and comorbidities in patients with systemic lupus erythematosus (SLE)Pathways of oxidative pathogenesis, such as oxidative modification of self antigens and T-cell dysfunction, have been identifiedOrgan systems in which the clinical importance of oxidative damage in SLE has been recognized include the cardiovascular and renal systems and the skinBiomarkers of oxidative stress correlate directly with disease activity in SLEDepletion of glutathione (reflecting oxidative stress) might have a pathogenic role; its reversal by N-acetylcysteine seems to have therapeutic benefit in mouse models and patients with SLE
引用
收藏
页码:674 / 686
页数:12
相关论文
共 50 条
  • [31] Animal Models of Molecular Pathology: Systemic Lupus Erythematosus
    Sang, Allison
    Yin, Yiming
    Zheng, Ying-Yi
    Morel, Laurence
    ANIMAL MODELS OF MOLECULAR PATHOLOGY, 2012, 105 : 321 - 370
  • [32] PATHOLOGY OF CARDIAC CONDUCTION SYSTEM IN SYSTEMIC LUPUS ERYTHEMATOSUS
    JAMES, TN
    RUPE, CE
    MONTO, RW
    ANNALS OF INTERNAL MEDICINE, 1965, 63 (03) : 402 - +
  • [33] CARDIOVASCULAR ASPECTS OF SYSTEMIC LUPUS-ERYTHEMATOSUS PATHOLOGY
    MOISEEV, VS
    TAREEVA, IE
    KARDIOLOGIYA, 1980, 20 (05) : 30 - 34
  • [34] Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies
    Ogishima, D
    Matsumoto, T
    Nakamura, Y
    Yoshida, K
    Kuwabara, Y
    PATHOLOGY INTERNATIONAL, 2000, 50 (03) : 224 - 229
  • [35] Placental pathology in systemic lupus erythematosus: A prospective study
    Magid, MS
    Kaplan, C
    Sammaritano, LR
    Peterson, M
    Druzin, ML
    Lockshin, MD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (01) : 226 - 234
  • [36] METABOLIC CONTROL OF SYSTEMIC LUPUS ERYTHEMATOSUS: CONVERGENCE OF GENETIC AND ENVIRONMENTAL FACTORS ON MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS REVEAL TREATMENT TARGETS IN LUPUS
    Perl, A.
    RHEUMATOLOGY, 2012, 51 : I9 - I10
  • [37] Update on the treatment of systemic lupus erythematosus
    Arango, Ana M.
    Reveille, John D.
    WOMENS HEALTH, 2006, 2 (04) : 605 - 616
  • [38] TREATMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    BURLINGAME, MB
    DELAFUENTE, JC
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (04): : 283 - 289
  • [39] Bromocriptine treatment of systemic lupus erythematosus
    Walker, SE
    LUPUS, 2001, 10 (10) : 762 - 768
  • [40] Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress
    Bahrehmand, F.
    Vaisi-Raygani, A.
    Kiani, A.
    Rahimi, Z.
    Tavilani, H.
    Ardalan, M.
    Vaisi-Raygani, H.
    Shakiba, E.
    Pourmotabbed, T.
    LUPUS, 2015, 24 (06) : 597 - 605